These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 15336593

  • 1. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
    Heikkinen AM, Niskanen LK, Salmi JA, Koulu M, Pesonen U, Uusitupa MI, Komulainen MH, Tuppurainen MT, Kröger H, Jurvelin J, Saarikoski S.
    Bone; 2004 Sep; 35(3):589-94. PubMed ID: 15336593
    [Abstract] [Full Text] [Related]

  • 2. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
    Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH.
    J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
    [Abstract] [Full Text] [Related]

  • 3. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
    Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Mäenpää PH.
    J Bone Miner Res; 2003 Feb; 18(2):319-24. PubMed ID: 12568409
    [Abstract] [Full Text] [Related]

  • 4. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT, Komulainen M, Kröger H, Honkanen R, Jurvelin J, Puntila E, Heikkinen AM, Alhava E, Saarikoski S.
    Osteoporos Int; 1998 Feb; 8(1):32-8. PubMed ID: 9692075
    [Abstract] [Full Text] [Related]

  • 5. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A.
    Ann Acad Med Stetin; 2003 Feb; 49():111-30. PubMed ID: 15552843
    [Abstract] [Full Text] [Related]

  • 6. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
    Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH.
    J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213
    [Abstract] [Full Text] [Related]

  • 7. COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss.
    MacDonald HM, McGuigan FA, New SA, Campbell MK, Golden MH, Ralston SH, Reid DM.
    J Bone Miner Res; 2001 Sep; 16(9):1634-41. PubMed ID: 11547832
    [Abstract] [Full Text] [Related]

  • 8. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial.
    Komulainen M, Kröger H, Tuppurainen MT, Heikkinen AM, Alhava E, Honkanen R, Jurvelin J, Saarikoski S.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):546-52. PubMed ID: 10022414
    [Abstract] [Full Text] [Related]

  • 9. The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.
    Saarto T, Vehmanen L, Elomaa I, Välimäki M, Mäkelä P, Blomqvist C.
    Br J Cancer; 2001 Apr 20; 84(8):1047-51. PubMed ID: 11308252
    [Abstract] [Full Text] [Related]

  • 10. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM, Parviainen M, Niskanen L, Komulainen M, Tuppurainen MT, Kröger H, Saarikoski S.
    J Clin Endocrinol Metab; 1997 Aug 20; 82(8):2476-82. PubMed ID: 9253321
    [Abstract] [Full Text] [Related]

  • 11. Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?
    Sirola J, Kröger H, Honkanen R, Sandini L, Tuppurainen M, Jurvelin JS, Saarikoski S.
    Osteoporos Int; 2003 Jan 20; 14(1):27-33. PubMed ID: 12577182
    [Abstract] [Full Text] [Related]

  • 12. Association between androgen receptor gene polymorphism and bone density in older women using hormone replacement therapy.
    Retornaz F, Paris F, Lumbroso S, Audran F, Tigoulet F, Michelon C, Jeandel C, Sultan C, Blain H.
    Maturitas; 2006 Nov 20; 55(4):325-33. PubMed ID: 16759824
    [Abstract] [Full Text] [Related]

  • 13. Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women.
    Salmen T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Mäenpää PH.
    Ann Med; 2003 Nov 20; 35(4):282-8. PubMed ID: 12846271
    [Abstract] [Full Text] [Related]

  • 14. Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women?
    Heikkinen AM, Kröger H, Niskanen L, Komulainen MH, Ryynänen M, Parviainen MT, Tuppurainen MT, Honkanen R, Saarikoski S.
    Maturitas; 2000 Jan 15; 34(1):33-41. PubMed ID: 10687880
    [Abstract] [Full Text] [Related]

  • 15. Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.
    Tiitinen A, Nikander E, Hietanen P, Metsä-Heikkilä M, Ylikorkala O.
    Maturitas; 2004 Jul 15; 48(3):321-7. PubMed ID: 15207898
    [Abstract] [Full Text] [Related]

  • 16. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
    Morita A, Iki M, Dohi Y, Ikeda Y, Kagamimori S, Kagawa Y, Matsuzaki T, Yoneshima H, Marumo F, JPOS Study Group.
    Int J Epidemiol; 2004 Oct 15; 33(5):979-88. PubMed ID: 15358739
    [Abstract] [Full Text] [Related]

  • 17. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
    Tuppurainen M, Härmä K, Komulainen M, Kiviniemi V, Kröger H, Honkanen R, Alhava E, Jurvelin J, Saarikoski S.
    Maturitas; 2010 Aug 15; 66(4):423-30. PubMed ID: 20547017
    [Abstract] [Full Text] [Related]

  • 18. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
    Legroux-Gerot I, Vignau J, Collier F, Cortet B.
    Calcif Tissue Int; 2008 Nov 15; 83(5):315-23. PubMed ID: 18836675
    [Abstract] [Full Text] [Related]

  • 19. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M, Cappagli B, Ciaponi M, Pepe A, Vacca F, Genazzani AR.
    Maturitas; 2008 Jan 20; 59(1):2-6. PubMed ID: 18063490
    [Abstract] [Full Text] [Related]

  • 20. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women.
    Maddalozzo GF, Widrick JJ, Cardinal BJ, Winters-Stone KM, Hoffman MA, Snow CM.
    Bone; 2007 May 20; 40(5):1244-51. PubMed ID: 17291843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.